Antidepressants/mood stabilizers: health insurance spending in France 2015

This statistic shows the distribution of health insurance expenditure for treatments with antidepressants or mood stabilizers (excluding pathologies) in France in 2015, by type. That year, the cost of ambulatory care treatments amounted to more than 1.3 billion euros.

Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2015, by type

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

May 2017



Survey time period


Supplementary notes

The source adds the following information: "Treatment Definition Algorithm: Persons who have received at least three ATC (Anatomic, Therapeutic and Chemical Class) N06A (except levotonin) antidepressant deliveries, lithium, Depakote or Depamide during the year n (at different dates), and who have no new psychiatric pathology."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Depression in the U.S."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.